Basic/Translational Science Investigator (BTSI)

Purpose

The purpose of the NANETS BTSI Award is to encourage scientists at the end of their fellowship who have secured a faculty appointment or scientists beginning their faculty appointment to pursue research focused on neuroendocrine tumors. 

Award Sponsor

The Neuroendocrine Tumor Research Foundation has supported this award since 2016.

Eligibility

The BTSI is awarded to scientists at the end of their fellowship or in the beginning of their faculty appointment, who are predominantly focused on lab-based, basic/translational research. The BTSI is intended to encourage scientific inquiry in the field of basic/translational science as it relates to NETs.

NANETS welcomes applications from candidates who meet the following criteria:

  • Candidates must have a MD, PhD, MD/PhD, DO degree or equivalent.
  • At the time of funding, candidates must be:
    • Within 6 years of starting their first faculty position and currently have an academic appointment at an accredited medical school or other institution in North America,
    • OR hold a postdoctoral fellowship appointment at an accredited medical school or other institution in North America.
  • Candidates must be a NANETS member in good standing.
  • Previous recipients of NBTSI, NCIS or NTIG awards are not eligible to apply.

BTSI Selection Criteria

Criteria for selection will include both the research proposal itself and the potential of the individual to make future scientific and/or clinical contributions to the neuroendocrine tumor field. Strong emphasis will be placed on the career development plan and the applicant’s personal statements, as well as the research proposal. The research proposals section should focus on research projects with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors. Appropriate projects would include (but are not limited to) risk factors, clinical outcomes, novel treatment strategies, and translational research projects with clear clinical significance. The research proposal can include the development of a clinical trial and/or correlative studies involving existing clinical trials.

Award Term

The NANETS Basic/Translational Science Investigator Award is a two-year $100,000 grant, awarding $50,000 in funding each year. The award period begins January 1.

Reporting Requirements

The recipient must provide NANETS with a written progress report of the project and a budget reconciliation bi-annually. At the end of the second calendar year, the progress summary must include the following:

  • Scientific summary of the research project
  • Budget reconciliation
  • Any lessons learned that would be useful to other research scientists
  • Investigator’s future clinical and research plans, especially in regards to the field of neuroendocrine tumors
  • Listing of reference citations for all articles or presentations arising from the recipient’s research project
  • Description of how the BTSI research grant has impacted recipient’s career

Application Review and Notification Process

Applications are reviewed and scored by the NANETS’ Scientific Review & Research Committee comprised of NET medical research experts. Criteria for selection will include both the research proposal itself and the potential of the individual to make future scientific and/or clinical contributions to the neuroendocrine tumor field. Strong emphasis will be placed on the career development plan and the applicant’s personal statements, as well as the research proposal. The research proposals section should focus on research projects with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors. Appropriate projects would include (but are not limited to) studies of neuroendocrine tumor biology, epidemiology, risk factors, clinical outcomes, novel treatment strategies, and translational research projects with clear clinical significance.  

Disclaimer
Funding is subject to the approval and availability of grant funds appropriated to NANETS. Therefore, NANETS reserves the right to alter the number of investigator awards, terms and allowances.